[Retracted] Clinical Efficacy and Safety of Tumor Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer

Table 4

T-lymphocyte subpopulation cell levels ().

Timepoint	Indices	Observation (n = 33)	Experimental (n = 33)	t-value	value
Before treatment	CD3+ (%)	30.47 ± 3.19	30.33 ± 3.15	0.179	0.858
	CD4+ (%)	26.78 ± 2.74	26.75 ± 2.72	0.045	0.946
	CD3+/CD4+	1.13 ± 0.17	1.15 ± 0.14	−0.522	0.603
After treatment	CD3+ (%)	33.17 ± 3.44	35.59 ± 3.65	−2.772	0.007
	CD4+ (%)	34.08 ± 3.58	36.19 ± 3.73	−2.344	0.022
	CD3+/CD4+	0.85 ± 0.08	0.94 ± 0.11	−3.801	<0.001

Note. indicates when compared with pretreatment.